Two or three issues side by side. Only issues that are open, upcoming or awaiting listing appear — those are the ones a comparison can act on, and the ones whose figures are actually published.
3 is the most that fits side by side. Remove one to add another.
| Comparing | SJ Shankesh Jewellers LimitedMainboard · Open | SP Symbiotec PharmalabMainboard · Upcoming | AE Augmont Enterprises LimitedMainboard · Upcoming |
|---|---|---|---|
| Issue | |||
| Board | Mainboard | Mainboard | Mainboard |
| Status | Open | Upcoming | Upcoming |
| Price band | ₹88 – ₹93 | ₹988 | ₹750 – ₹788 |
| Lot size | 160 shares | — | |
A row is shown only where at least one of these issues has published the figure; a dash means that company has not. Nothing here is a recommendation — CAPITA1 is not registered with SEBI as an investment adviser or a research analyst.
| 19 shares |
| Minimum investmentOne lot at the upper band | ₹14,880 | — | ₹14,972 |
|---|
| Issue size | ₹367.18 Cr | — | ₹825 Cr |
|---|
| Face value | ₹5 | — | ₹5 |
|---|
| Registrar | KFIN Technologies Limited | — | MUFG Intime India Private Limited |
|---|
| Timeline | |||
|---|---|---|---|
| Open date | 18 Aug 2026 | 24 Aug 2026 | 21 Aug 2026 |
| Close date | 20 Aug 2026 | 27 Aug 2026 | 25 Aug 2026 |
| Allotment date | 21 Aug 2026 | 28 Aug 2026 | 26 Aug 2026 |
| Listing date | 25 Aug 2026 | 1 Sep 2026 | 28 Aug 2026 |
| Valuation | |||
|---|---|---|---|
| P/E ratioAt the upper band. Null where earnings are negative. | 10.23x | 51.73x | 19.48x |
| EPS | ₹9.09 | ₹19.1 | ₹40.45 |
| NAV per share | ₹17.82 | ₹184.69 | ₹111 |
| Return on equity | 50.94% | 11.19% | 51.04% |
| Return on net worth | 50.94% | 9.48% | 49.52% |
| Return on capital employed | 41.57% | 11.56% | 40.27% |
| EBITDA margin | 9.68% | 26.59% | 0.41% |
| Debt to equity | 0.80 | — | 0.01 |
| Market | |||
|---|---|---|---|
| Grey market premiumUnofficial estimate — not an exchange price | ₹1.5 (+1.61%) | — | ₹160 |
| Subscribed (overall) | 0.85x | — | 0.00x |
| Subscribed (retail) | 1.00x | — | — |